Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Jin Medical International (ZJYL) Shares Outstanding (2022)

Jin Medical International (ZJYL) has disclosed Shares Outstanding for 1 consecutive years, with $135.0 million as the latest value for Q3 2022.

  • Quarterly Shares Outstanding changed N/A to $135.0 million in Q3 2022 from the year-ago period, while the trailing twelve-month figure was $135.0 million through Sep 2022, changed N/A year-over-year, with the annual reading at $135.0 million for FY2022, 0.0% changed from the prior year.
  • Shares Outstanding hit $135.0 million in Q3 2022 for Jin Medical International.
  • In the past five years, Shares Outstanding ranged from a high of $135.0 million in Q3 2022 to a low of $135.0 million in Q3 2022.